Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia.

Lavretsky H, Ercoli L, Siddarth P, Bookheimer S, Miller K, Small G.

Am J Geriatr Psychiatry. 2003 Nov-Dec;11(6):667-73.

2.

Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.

Dik MG, Jonker C, Comijs HC, Bouter LM, Twisk JW, van Kamp GJ, Deeg DJ.

Neurology. 2001 Dec 26;57(12):2217-22.

PMID:
11756600
3.

APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.

Bunce D, Fratiglioni L, Small BJ, Winblad B, Bäckman L.

Neurology. 2004 Sep 14;63(5):816-21.

PMID:
15365129
4.
5.

Impact of APOE status on cognitive maintenance in healthy elderly persons.

Zehnder AE, Bläsi S, Berres M, Monsch AU, Stähelin HB, Spiegel R.

Int J Geriatr Psychiatry. 2009 Feb;24(2):132-41. doi: 10.1002/gps.2080.

PMID:
18615849
6.

Gene-behavior interaction of depressive symptoms and the apolipoprotein E {varepsilon}4 allele on cognitive decline.

Rajan KB, Wilson RS, Skarupski KA, Mendes de Leon CF, Evans DA.

Psychosom Med. 2014 Feb;76(2):101-8. doi: 10.1097/PSY.0000000000000029.

7.

APOE-epsilon4, depressive symptoms, and cognitive decline in Chinese older adults: Singapore Longitudinal Aging Studies.

Niti M, Yap KB, Kua EH, Ng TP.

J Gerontol A Biol Sci Med Sci. 2009 Feb;64(2):306-11. doi: 10.1093/gerona/gln013.

8.

Depressive symptoms moderate the influence of the apolipoproteine epsilon4 allele on cognitive decline in a sample of community dwelling older adults.

Corsentino EA, Sawyer K, Sachs-Ericsson N, Blazer DG.

Am J Geriatr Psychiatry. 2009 Feb;17(2):155-65. doi: 10.1097/JGP.0b013e31818f3a6b.

9.

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.

Arch Neurol. 2005 Jun;62(6):975-80.

PMID:
15956169
10.

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.

Dik MG, Jonker C, Bouter LM, Geerlings MI, van Kamp GJ, Deeg DJ.

Neurology. 2000 Apr 11;54(7):1492-7.

PMID:
10751265
11.

Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.

Qiu C, Winblad B, Fratiglioni L.

Neurol Res. 2006 Sep;28(6):650-6.

PMID:
16945218
12.

APOE genotype and cognitive decline in a middle-aged cohort.

Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E; Atherosclerosis Risk in Communities (ARIC) Study Investigators..

Neurology. 2005 Jan 25;64(2):268-76.

PMID:
15668424
13.

Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.

Yip AG, Brayne C, Easton D, Rubinsztein DC; Medical Research Council Cognitive Function Ageing Study (MRC CFAS)..

J Med Genet. 2002 Sep;39(9):639-43.

14.

APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.

Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA.

Neurology. 2004 Oct 26;63(8):1399-402.

PMID:
15505155
15.

Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.

Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.

Arch Neurol. 2005 Mar;62(3):454-9.

PMID:
15767511
16.

Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.

Dik MG, Deeg DJ, Bouter LM, Corder EH, Kok A, Jonker C.

Stroke. 2000 Oct;31(10):2431-6.

17.

Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.

Batterham PJ, Bunce D, Cherbuin N, Christensen H.

Am J Geriatr Psychiatry. 2013 Oct;21(10):1010-9. doi: 10.1016/j.jagp.2013.01.035.

PMID:
23567378
18.

Differential effects of the APOE genotype on brain function across the lifespan.

Filippini N, Ebmeier KP, MacIntosh BJ, Trachtenberg AJ, Frisoni GB, Wilcock GK, Beckmann CF, Smith SM, Matthews PM, Mackay CE.

Neuroimage. 2011 Jan 1;54(1):602-10. doi: 10.1016/j.neuroimage.2010.08.009.

PMID:
20705142
19.

The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.

O'Hara R, Yesavage JA, Kraemer HC, Mauricio M, Friedman LF, Murphy GM Jr.

J Am Geriatr Soc. 1998 Dec;46(12):1493-8.

PMID:
9848808
20.

Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.

Ma F, Wang J, Miao R, Zhao W, Wang Q.

Neuropsychobiology. 2011;64(2):102-9. doi: 10.1159/000324991.

PMID:
21701228
Items per page

Supplemental Content

Support Center